3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
70
Neoplasm Metastasis
20
Rectal Neoplasms
19
Colonic Neoplasms
17
Neoplasms
11
Cholangiocarcinoma
7
Carcinoma, Non-Small-Cell Lung
7
Head and Neck Neoplasms
6
Esophageal Neoplasms
6
Breast Neoplasms
6
Carcinoma, Squamous Cell
5
Triple Negative Breast Neoplasms
4
Pancreatic Neoplasms
4
Ovarian Neoplasms
4
Lung Neoplasms
4
Colorectal Cancer Metastatic
4
Squamous Cell Carcinoma of Head and Neck
3
Recurrence
3
Prostatic Neoplasms
3
Inflammatory Breast Neoplasms
3
Carcinoma
3
Adenocarcinoma Of Esophagus
3
Adenocarcinoma
3
Urinary Bladder Neoplasms
2
Stomach Neoplasms
2
Fallopian Tube Neoplasms
2
Biliary Tract Neoplasms
2
Uterine Cervical Neoplasms
1
Serotonin Syndrome
1
Salivary Gland Malignancy
1
Interventions
Gemcitabine
26
Capecitabine
16
Oxaliplatin
14
Fluorouracil
13
Cisplatin
12
Leucovorin
9
pembrolizumab
5
Erlotinib Hydrochloride
5
Bevacizumab
5
durvalumab
4
Trastuzumab
4
Specimen Handling
4
Sorafenib
4
Magnetic Resonance Spectroscopy
4
130-nm albumin-bound paclitaxel
4
trifluridine tipiracil drug combination
3
Lapatinib
3
Irinotecan
3
Carboplatin
3
Biopsy
3
tremelimumab
2
toripalimab
2
regorafenib
2
lenvatinib
2
dehydroftorafur
2
cobimetinib
2
atezolizumab
2
anlotinib
2
Nivolumab
2
N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Gallbladder Neoplasms
×
Panitumumab
×
Clear all
NCT01308840
2016-08-17
UGIH09067
University of Rochester
Phase 2
Completed
31 enrolled
10 charts